ADA Scientific Sessions 2025 Abstract

The Impact of a Commercial Telehealth Medical Weight Management and GLP-1 Behavioral Program on Quality of Life and Eating Behavior Outcomes in a Six-Month Single-Arm Study

By Leslie J. Heinberg, Alexandra M. Lee, Gary D. Foster, Michelle Cardel

Trial in peopleInterventions

The paper

Leslie J. Heinberg, Alexandra M. Lee, Gary D. Foster, Michelle Cardel

Cleveland

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 1732-P

doi.org/10.2337/db25-1732-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes